CAR T‑cell therapy cures three autoimmune diseases
Why it matters: The therapy restored daily function for a 45‑year‑old woman, proving multi‑disease CAR T can work in humans.
- CAR T‑cell therapy engineered to target three autoimmune diseases at once (per study)
- Patient went from bedridden to “perfectly fine” after treatment (clinician report)
- Researchers say the approach could streamline care for complex autoimmune cases, though long‑term safety remains under study
A 45‑year‑old woman with three autoimmune disorders was revived from bedridden status after receiving a personalized CAR T‑cell therapy that reprogrammed her immune system to eliminate the rogue cells. The treatment, which targeted all three conditions simultaneously, shows promise for multi‑disease immunotherapy.
